Diagnosing SI Joint Disorders SI Joint Injection Demonstration

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=iv9vAz1qRl4

Learn more about the sacroiliac joint at http://si-bone.com. • The current standard is that SI joint injection should be performed under fluoroscopic guidance, utilizing contrast to confirm needle placement, injecting no more than 2 ccs. of solution whether it's a diagnostic and/or a therapeutic injection. • The percent pain reduction that we're looking for after a diagnostic sacroiliac joint pain injection under fluoroscopy is performed is greater than or equal to a 75% pain reduction when comparing pre-procedure and post-procedure visual analog pain scores within 15 to 30 minutes. • We use the provocative maneuvers or simple functional activities like sitting, standing and walking as typical measures of the pain reduction. Furthermore, patients will take home a pain diary log where they'll record their pain intensity scores every two hours for up to 24 hours. • After a therapeutic sacroiliac joint injection is performed a pelvic strengthening and stabilization program is typically the next step in the treatment plan. This program typically lasts for as long as six to eight weeks. • When patients are unresponsive to therapeutic sacroiliac joint injections in conjunction with physical rehabilitation treatment then the next step in the treatment plan would be to consider a minimally invasive SI joint fusion. • Amish Patel, DO - paid consultant of SI-BONE • The iFuse Implant System is intended for sacroiliac fusion for conditions including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis. This includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months. • There are potential risks associated with the iFuse Implant System. It may not be appropriate for all patients and all patients may not benefit. For information about the risks, visit: www.si-bone.com/risks • U.S. Patent Nos. 8,202,305; 8,840,623; 8,986,348; and 9,039,743; pending U.S. and foreign patent applications. • (C) 2012. SI-BONE, Inc. All rights reserved.SI-BONE and iFuse Implant System are registered trademarks of SI-BONE, Inc.

#############################

New on site